362 related articles for article (PubMed ID: 32407980)
1. Agrochemicals with estrogenic endocrine disrupting properties: Lessons Learned?
Vandenberg LN; Najmi A; Mogus JP
Mol Cell Endocrinol; 2020 Dec; 518():110860. PubMed ID: 32407980
[TBL] [Abstract][Full Text] [Related]
2. Assessment of chemical effects on aromatase activity using the H295R cell line.
Higley EB; Newsted JL; Zhang X; Giesy JP; Hecker M
Environ Sci Pollut Res Int; 2010 Jun; 17(5):1137-48. PubMed ID: 20087668
[TBL] [Abstract][Full Text] [Related]
3. Introduction to "screening for endocrine activity-experiences with the US EPA's endocrine disruptor screening program and future considerations".
Marty S
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):1-2. PubMed ID: 24510782
[No Abstract] [Full Text] [Related]
4. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results.
Borgert CJ; Mihaich EM; Quill TF; Marty MS; Levine SL; Becker RA
Regul Toxicol Pharmacol; 2011 Apr; 59(3):397-411. PubMed ID: 21251942
[TBL] [Abstract][Full Text] [Related]
5. Endocrine profiling and prioritization of environmental chemicals using ToxCast data.
Reif DM; Martin MT; Tan SW; Houck KA; Judson RS; Richard AM; Knudsen TB; Dix DJ; Kavlock RJ
Environ Health Perspect; 2010 Dec; 118(12):1714-20. PubMed ID: 20826373
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program.
Borgert CJ; Mihaich EM; Ortego LS; Bentley KS; Holmes CM; Levine SL; Becker RA
Regul Toxicol Pharmacol; 2011 Nov; 61(2):185-91. PubMed ID: 21803110
[TBL] [Abstract][Full Text] [Related]
7. Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.
Browne P; Noyes PD; Casey WM; Dix DJ
Environ Health Perspect; 2017 Sep; 125(9):096001. PubMed ID: 28934726
[TBL] [Abstract][Full Text] [Related]
8. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
[TBL] [Abstract][Full Text] [Related]
9. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study.
Paul Friedman K; Papineni S; Marty MS; Yi KD; Goetz AK; Rasoulpour RJ; Kwiatkowski P; Wolf DC; Blacker AM; Peffer RC
Crit Rev Toxicol; 2016 Oct; 46(9):785-833. PubMed ID: 27347635
[TBL] [Abstract][Full Text] [Related]
10. Hypothesis-driven weight of evidence evaluation indicates styrene lacks endocrine disruption potential.
Borgert CJ
Crit Rev Toxicol; 2023 Feb; 53(2):53-68. PubMed ID: 37216681
[TBL] [Abstract][Full Text] [Related]
11. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
Bishop PL; Willett CE
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143
[TBL] [Abstract][Full Text] [Related]
12. Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.
Stump DG; O'Connor JC; Lewis JM; Marty MS
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):43-62. PubMed ID: 24510766
[TBL] [Abstract][Full Text] [Related]
13. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
Ankley GT; Gray LE
Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061
[TBL] [Abstract][Full Text] [Related]
14. Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond.
McLachlan JA
Andrology; 2016 Jul; 4(4):684-94. PubMed ID: 27230799
[TBL] [Abstract][Full Text] [Related]
15. Organochlorine pesticides: Agrochemicals with potent endocrine-disrupting properties in fish.
Martyniuk CJ; Mehinto AC; Denslow ND
Mol Cell Endocrinol; 2020 May; 507():110764. PubMed ID: 32112812
[TBL] [Abstract][Full Text] [Related]
16. Application of an integrated testing strategy to the U.S. EPA endocrine disruptor screening program.
Willett CE; Bishop PL; Sullivan KM
Toxicol Sci; 2011 Sep; 123(1):15-25. PubMed ID: 21642633
[TBL] [Abstract][Full Text] [Related]
17. Chlorpyrifos: weight of evidence evaluation of potential interaction with the estrogen, androgen, or thyroid pathways.
Juberg DR; Gehen SC; Coady KK; LeBaron MJ; Kramer VJ; Lu H; Marty MS
Regul Toxicol Pharmacol; 2013 Aug; 66(3):249-63. PubMed ID: 23524272
[TBL] [Abstract][Full Text] [Related]
18. Analysis of EPA's endocrine screening battery and recommendations for further review.
Schapaugh AW; McFadden LG; Zorrilla LM; Geter DR; Stuchal LD; Sunger N; Borgert CJ
Regul Toxicol Pharmacol; 2015 Aug; 72(3):552-61. PubMed ID: 26044367
[TBL] [Abstract][Full Text] [Related]
19. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.
Becker RA; Friedman KP; Simon TW; Marty MS; Patlewicz G; Rowlands JC
Regul Toxicol Pharmacol; 2015 Apr; 71(3):398-408. PubMed ID: 25656492
[TBL] [Abstract][Full Text] [Related]
20. Agrochemicals in freshwater systems and their potential as endocrine disrupting chemicals: A South African context.
Horak I; Horn S; Pieters R
Environ Pollut; 2021 Jan; 268(Pt A):115718. PubMed ID: 33035912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
